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Abstract 
Searching for hormone-regulated genes in testicular Sertoli cells, we cloned and sequenced a cDNA of 3108 base pairs, named 
LRPRl (signifying leucine-rich primary response gene 1). This cDNA sequence has an open reading frame of 2238 base pairs encoding 
a leucine-rich protein of 746 amino acid residues with a relative molecular mass of 85.6 kDa. As much as 16% of the amino acid 
residues is leucine. Database analysis revealed significant similarity of LRPRl to the human brain cDNA sequence ESTO0443, but not 
to any other sequences present in databases. The expression of LRPRI mRNA in Sertoli cells is strongly and rapidly up-regulated by 
follicle-stimulating hormone (FSH). The level of LRPRl mRNA was very low in Sertoli cells isolated from 21-day-old rats and 
cultured for 3 days in the absence of FSH, but LRPRI mRNA expression was markedly increased within 2 h after addition of FSH to 
these cultures. A maximal response was reached within 4 h. Dibutyryl-cyclic AMP [(Bu)+AMP] and forskolin had similar effects 
compared to FSH, indicating that CAMP acts as a second messenger in the regulation of LRPRl expression. The up-regulation of 
LRPRl mRNA expression by FSH was also observed in the presence of the protein synthesis inhibitor cycloheximide, indicating that 
FSH regulates LRPRI mRNA expression through a direct mechanism which does not require de novo protein synthesis. Thus, LRPRI 
represents a primary response gene in FSH action on Sertoli cells. The presently available data indicate that LRPRI mRNA expression 
is regulated specifically by FSH, since several other hormones and growth factors did not affect LRPRI mRNA expression in the 
cultured Sertoli cells. LRPRI mRNA expression is relatively high in testis, ovary and spleen. A much lower mRNA level was found in 
brain and lung, and no expression was detected in liver, kidney, heart, muscle, pituitary gland, prostate, epididymis and seminal vesicle. 
The basal level of testicular LRPRI expression in intact 21-day-old rats was markedly increased within several hours after a single i.p. 
injection of FSH, indicating that in vivo LRPRI mRNA expression may appear to be a useful parameter to evaluate testicular FSH 
action. 
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1. Introduction 
Follicle-stimulating hormone (FSH) from the pituitary 
gland and testosterone from testicular Leydig cells are 
generally considered to be the main regulators of sper- 
matogenesis. FSH is thought o play a major role in the 
initiation of spermatogenesis in immature mammals, but 
is also involved in quantitative and qualitative mainte- 
nance of spermatogenesis in adult animals, in particular in 
primates (Clermont and Harvey, 1967; Steinberger, 1971; 
*Corresponding author, Fax: +3 1 10 4366832. 
Hansson et al., 1975a; Means et al., 1976; Marshall et al., 
1986; Moudgal et al., 1992). This is supported by the 
observation that experimental immunization of male bon- 
net monkeys to ovine-FSH resulted in reversible infertil- 
ity (Moudgal et al., 1992). This infertility involved a de- 
creased number of spermatozoa in the ejaculate, but also a 
reduced fertilizing capacity of the remaining spermatozoa 
(Moudgal et al., 1992). 
The long-term effect of FSH on Sertoli cells may con- 
cern the maturation and maintenance of differentiated 
properties of these cells. This action of FSH includes 
protein phosphorylation and regulation of the synthesis of 
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many proteins such as androgen-binding protein (Dor- 
rington et al., 1975; Hagenas et al., 1975; Hansson et al., 
1975b), transferrin (Huggenvik et al., 1987) tissue type 
plasminogen activator (Bardin et al., 1994; Nargolwalla et 
al., 1990), steel factor (Rossi et al., 1993) a-inhibin 
(Toebosch et al., 1988; Klaij et al., 1990) and c-fos (Hall 
et al., 1988). 
With respect o the kinetics of the stimulation of pro- 
tein synthesis in Sertoli cells by FSH, both slow and rapid 
responses are found. FSH-induced stimulation of andro- 
gen-binding protein production (Dorrington et al., 1975; 
Hagenas et al., 1975; Hansson et al., 1975b) and transfer- 
rin (Huggenvik et al., 1987) by Sertoli cells is a slow 
process which takes many hours to reach its maximum. 
Several other responses of Sertoli cells to FSH are much 
more rapid. These include the effect of FSH on the tran- 
scription of the genes encoding tissue type plasminogen 
activator (Bardin et al., 1994; Nargolwalla., 1990) and a- 
inhibin (Toebosch et al., 1988; Klaij et al., 1990). Within 
1-2 h of stimulation of cultured Sertoli cells with FSH, 
mRNA expression levels for these genes have already 
significantly increased, and it takes approximately 6 h of 
FSH exposure to obtain maximal effects. One of the most 
rapid responses of cultured Sertoli cells to FSH is the in- 
duction of c-fos mRNA expression (Hall et al., 1988). 
The c-fos gene, and also the a-inhibin gene, show a pri- 
mary response to FSH, which implies that de novo protein 
synthesis is not required for stimulation of transcription. 
Such a response may result from activation of pre- 
existing transcription factors through CAMP-dependent 
protein kinases. 
Most, if not all, known Sertoli cell genes that show 
FSH-regulated transcription and protein synthesis, do not 
respond specifically to FSH. Reventos et al. (1988) have 
shown that androgen-binding protein mRNA expression 
in rat testis is also stimulated by testosterone. Transferrin 
mRNA expression can be influenced by many hormones 
and growth factors, including insulin and retinol 
(Huggenvik et al., 1987). C-fos and a-inhibin mRNA 
expression in Sertoli cells are also regulated by other 
factors besides FSH. Both the testicular paracrine factor 
PModS and fibroblast growth factor (FGF) can regulate 
c-fos mRNA expression in cultured Sertoli cells (Smith et 
al., 1989; Norton and Skinner, 1992) whereas a-inhibin 
mRNA expression in vitro is up-regulated when the Ser- 
toli cells are cultured in medium conditioned by early 
spermatids (Pineau et al., 1990). 
To better understand the molecular mechanisms in- 
volved in regulation of Sertoli cell development by FSH, 
more information about key regulatory genes that are 
responsive to FSH is essential. In the present report we 
describe the isolation and characterization of a new 
cDNA, named leucine-rich primary response gene- 1 
(LRPRZ), that was isolated from a rat Sertoli cell cDNA 
library. LRPRl mRNA expression is very rapidly up- 
regulated by FSH. Furthermore, LRPRI responds pecifi- 
cally to FSH, and represents a primary response gene in 
Sertoli cells exposed to FSH. 
2. Materials and methods 
2.1. Cells 
Sertoli cells were isolated from testes of 21-day-old 
rats as described previously (Themmen et al., 1991). The 
cells were cultured for 48 h in Eagle’s minimal essential 
medium (Gibco BRL, Middlesex, UK), supplemented 
with antibiotics, non-essential mino acids, and 1% fetal 
calf serum (MEM/FCS), at 37°C under 5% COP in air in 
80 cm* plastic culture flasks (Costar, Cambridge, USA). 
Subsequently, the Sertoli cell cultures were exposed for 
2 min to a hypo-osmotic shock by using tenfold diluted 
MEM in water (Toebosch et al., 1989), followed by incu- 
bation for another 24-h period in MEM with 0.1% (w/v) 
bovine serum albumin (fraction V; Sigma, St Louis, MO, 
USA) (MEM/BSA). Finally, the cells were incubated in 
MEM/BSA for different time periods with ovine-FSH- 
S16 (NIH, Bethesda, MD, USA), dibutyryl-cyclic AMP 
((Bu)zcAMP), forskolin (Boehringer, Mannheim, Ger- 
many), insulin-like growth factor-I (IGF-I) (kind gift 
from Dr. J. Foekens), insulin (Sigma), R1881 (Nen, Bos- 
ton, MA, USA), 4&phorbol- 12-myristate-13-acetate 
(PMA) (Sigma), 4/?-phorbolmonoacetate (PA) (Sigma), 
actinomycin D (Boehringer) or cycloheximide (Sigma). 
The efficiency of actinomycin D and cycloheximide 
treatment on Sertoli cells has been determined previously 
by measuring r3H]uridine and [J4C]leucine incorporation 
in the presence or absence of the inhibitor (Klaij et al., 
1990). Actinomycin D and cycloheximide inhibited RNA 
synthesis by 98 r 1% and protein synthesis by 96 + 2%, 
respectively. 
To determine in vivo FSH effects on LRPRZ mRNA 
expression, 21-day-old rats were injected i.p. with 1 ,ug 
ovine FSH-S16 per gram body weight. After different 
time periods the rats were sacrificed, and total testicular 
RNA was isolated. All animal care was performed in ac- 
cordance with the NIH Guide for the Care and Use of 
Laboratory Animals. 
2.2. RNA 
Isolation of RNA from Sertoli cells and total tissue was 
performed as described by Auffray and Rougeon (1980). 
For Northern blotting, RNA was separated in 1% (w/v) 
agarose/formaldehyde g ls, and blotted on Hybond N+ 
nylon membrane filters (Amersham, Buckinghamshire, 
UK). The blots were hybridized overnight at 42°C with 
32P-labelled LRPRZ cDNA probe in 50% (v/v) forma- 
mide, 5x SSC, 5 X Denhardt’s, 1% (w/v) SDS, 50 mM 
phosphate buffer (pH 6.8), containing 1OO~glml herring 
sperm DNA (Sambrook et al., 1989). After hybridization, 
the blots were washed to a final stringency of 0.1 X 
SSC/O.S% (w/v) SDS at 42’C, and autoradiography was 
performed to visualize the bands. 
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For the RNase protection assay, a 322 bp BarnHI-BglII 
fragment containing bp 1769-2091 from LRPRl was 
subcloned in pBluescript KS (Stratagene, La Jolla, CA, 
USA) and used to generate [32P]UTP-labelled anti-sense 
transcripts in vitro. The control glyceraldehyde 3-phos- 
phate dehydrogenase (GAPDH) RNA probe was synthe- 
sized using a construct containing a3 10 bp XhoI fragment 
from rat GAPDH cDNA (Fort et al., 1985). Approxi- 
mately 5 x 104 cpm of LRPRZ probe was mixed with 
5 pg of total RNA in a total volume of 30 ,ul hybridization 
mixture containing 40 mM Pipes (pH 6.4), 1 mM EDTA, 
0.4 M NaCl and 80% (v/v) formamide. The hybridiza- 
tions were performed overnight at 45°C. To test if equal 
amounts of RNA were present, GAPDH was used in a 
separate RNase protection assay. For LRPRI, one specific 
322 bp protected fragment was found. However, some 
less abundant non-specific bands can also be detected. 
The RNase protection assay, as well as all general mo- 
lecular biology techniques were carried out as described 
by Sambrook et al. (1989). The autoradiograms shown 
are representative of at least two independent experi- 
ments. 
2.3. Cloning of LRPRI 
A Sertoli cell directional cDNA library in pBluescript 
SK (Stratagene) (Baarends et al., 1994) was screened us- 
ing a DNA amplification approach with Taq DNA po- 
lymerase (Sphaero Q, Leiden, The Netherlands). The 
strategy of the screening was based on the working hypo- 
thesis that primary response genes might encode C2HZ- 
type zinc finger containing transcription factors. There- 
fore, the primers were the vector-based reverse Ml3 
sequence primer (5’-AACAGCTATGACCATG-3’) and 
an antisense degenerate primer based on the connecting 
amino acid sequence of the C,H2-type of zinc finger 
proteins (5’-GCAITCATAIGGITTITCICGIGTGTG-3’) 
(Thiessen, 1990). The primers were annealed for 5 min at 
37”C, after which two amplification cycles were per- 
formed (2 min synthesis at 72”C, 1 min denaturation at 
95’C, and 2 min annealing at 37”(Z), followed by two 
cycles with the annealing temperature at 41’C. The am- 
plification was continued for 26 cycles using an annealing 
temperature of 45°C. The resulting amplification products 
were separated on a 2% (w/v) agarose gel. The smear 
containing the amplified DNA was isolated from the 
gel using the QiaEx gel extraction kit (Qiagen, 
Chatsworth, CA, USA), and subjected to 30 cycles of 
DNA amplification (1 min denaturation at 95”C, 2 min 
annealing at 45”C, 2 min primer extension at 72°C). The 
resulting product was blunt-ended with Klenow fragment 
of E. coli DNA polymerase I and T4 DNA polymerase 
(Boehringer), and ligated to pBluescript-KS (Stratagene) 
that was treated with SmaI and calf intestinal phosphatase 
(Boehringer). Ninety insert-containing clones were 
picked. Clones were tested for FSH and androgen induc- 
tion by hybridisation to Northern blots containing total 
RNA isolated from 21-day-old Sertoli cells, cultured for 
4 h or 24 h in the presence of FSH or the synthetic andro- 
gen R1881 (NEN). One of the clones was found to be 
stimulated by FSH but not by androgens. This clone was 
used to screen the Sertoli cell cDNA library, and three 
cDNA clones were isolated. The largest insert was res- 
cued according to the protocol supplied by the supplier 
(Stratagene). For sequencing the LRPRZ cDNA clone, 
partial overlapping clones were obtained by ExoIII nucle- 
ase deletion using the Erase-a-base method (Promega, 
Madison, WI, USA). The subclones were sequenced by 
the dideoxy chain termination method (Sanger et al., 
1977) in both orientations, using T7 DNA polymerase 
(Pharmacia, Uppsala, Sweden). After sequencing LRPRZ, 
database analysis was performed using the program suite 
of the University of Wisconsin Genetics Computer Group 
(Devereux, 1992). 
2.4. In vitro transcription and translation 
For in vitro transcription, the LRPRl plasmid was line- 
arized using XhoI. Then, the linearized plasmid was puri- 
fied and treated with proteinase K as described by Sam- 
brook (1989). A second purification step was performed 
by extraction with phenol/chloroform and precipitation 
with ethanol. An amount of 500 ng of linearized LRPRl 
plasmid was added to 20 U RNasin (Promega), 0.4 mM 
rUTP, rGTP, rATP and rCTP (Pharmacia), 30 mM dithio- 
threitol, 25 U T3 RNA polymerase (Statagene) and 1 X 
transcription buffer (40 mM Tris, 50 mM NaCl, 8 mM 
MgCl, and 2 mM spermidine; Stratagene) in a total vol- 
ume of 25 ~1. Transcription was carried out at 37°C for 
1 h. Subsequently, 10 U of RNase-free DNase I (Strata- 
gene) was added, and DNA digestion took place for 
30 min at 37°C. The RNA was purified by phenol/chloro- 
form extraction, precipitated with ethanol and dissolved 
in 10~1 RNase-free H,O. A 10% portion of this RNA was 
used for in vitro translation in the presence of i3”S]- 
methionine, which was performed by using the rabbit 
reticulocyte lysate system (Promega). The translation 
products were separated by SDS-PAGE (7% w/v acryla- 
mide separating el, 4% w/v acrylamide stacking gel) 
(Laemli, 1970). After electrophoresis, the gel was fixed 
and dried. Autoradiography was performed to visualize 
the bands. 
3. Results 
3.1. Cloning and characterization of LRPRl 
Using a DNA amplification approach, we isolated 
LRPRI from a Sertoli cell cDNA library. This cDNA 
clone represents a mRNA, of which expression in Sertoli 
cells is rapidly induced by FSH. Sequence analysis (Fig. 
1) showed that the largest cDNA clone has a length of 
3108 bp. The zinc-finger primer sequence, used to am- 
plify the DNA, can be found at position 2195. However, 
only 19 out of the 27 nucleotides in the primer can be 
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found in the LRPRl cDNA sequence. These nucleotides 
encode an amino acid sequence in which 4 out of the 9 
amino acids of the C,H2 zinc finger connecting peptide 
(Thiessen, 1990) are present. Neither the N-terminal cys- 
teines nor the C-terminal histidines can be found. This 
agrees with the absence of a &Hz zinc finger in the 
LRPRl protein sequence. The longest open reading frame 
encodes a protein of 746 amino acid residues and a rela- 
tive molecular mass of 85.6 kDa. The 3’ untranslated re- 
gion has a length of 670 bp and contains a canonical 
polyadenylation site at position 3074. 
The first in frame ATG is present at position 206 of the 
total length of the clone. This translation start site was 
compared to the Kozak consensus equence for initiation 
of translation in vertebrates [GCC(A/G)CCATGG] 
(Kozak, 1987, 1989). Positions -3 (three nucleotides up- 
stream from the ATG codon) and i-4, which are consid- 
ered to be the most discriminating nucleotides in the 
Kozak consensus sequence for translation start sites 
(Kozak, 1987, 1989), conform with this consensus, 
whereas the other nucleotides differ. Higher similarity 
(nucleotides at positions -1 and -2 incorrect) with the 
Kozak consensus equence was found at the ATG codon 
at position 88 1. In vitro transcription of the LRPRl 
cDNA, followed by in vitro translation, revealed that both 
translation start sites are operational in a cell-free system. 
Two major and some minor protein bands were visible on 
a polyacrylamide gel after in vitro translation (Fig. 2). 
The size of the upper band conforms with the expected 
molecular mass of 85.6 kDa. The lower band with a mo- 
lecular mass of approximately 60 kDa can be explained 
by secondary starts at the AUG at position 88 1. 
Comparison of nucleotide and amino acid sequences to 
the EMBL and GenBank databases revealed only one 
1 2 3 
entry with significant homology (Fig. 3). This homolo- 
gous sequence, EST00443, which was randomly chosen 
from a human cDNA library as an expressed sequence tag 
(Adams et al., 1992), shows 80.6% and 74.0% identity 
with LRPRl at the nucleotide and amino acid levels, re- 
spectively. No further information on EST00443 is avail- 
able. 
Several small protein sequence motifs can be found in 
LRPRl. Consensus N-glycosylation sites are located at 
amino acid residues 260, 362 and 607. Also, one CAMP/ 
cGMP-dependent protein kinase phosphorylation site, 
several protein kinase C phosphorylation sites, and two 
tyrosine kinase phosphorylation sites were identified (Fig. 
1). A leucine zipper pattern was found at position 530 of 
the protein sequence. This protein-protein interaction 
domain is present in many gene regulatory proteins, such 
as the CAMP responsive element binding proteins 
(CREBP family), transcription factors of the APl family, 
and myc proto-oncogenes (Landschulz et al., 1988; 
O’Shea et al., 1989; Busch and Sassone-Corsi, 1990). The 
protein encoded by LRPRl is leucine-rich; 16% of the 
amino acid residues is leucine. 
3.2. Hormonal and developmental control of LRPRI 
expression 
To study hormonal control of LRPRI mRNA expres- 
sion in Sertoli cells, the isolated cells were pre-incubated 
for 3 days (see Section 2), and then treated for 4 h with 
increasing doses of FSH. Northern blot analysis of total 
RNA isolated from these Sertoli cells, using a LRPRI 
cDNA probe, revealed a rapidly responding 4 kb mRNA 
that is induced by FSH. This action of FSH occurs 
through the CAMP transduction pathway, as indicated by 
the response in cells treated with either 0.5 mM 
4 M 
97 kDa 
66 kDa 
45 kDa 
Fig. 2. Autoradiogram of the in vitro transcription/translation assay. The in vitro translation assay was performed as described in Section 2, with addi- 
tion of luciferase mRNA (positive control, lane l), no RNA (negative control, lane 2) or LRPRl mRNA obtained by 2 independent in vitro transcrip 
tion procedures (lanes 3 and 4). 
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I. 
1574 1633 
LRPRl 
EST00443 
LRPRl 
EST00443 
LRPRl 
EST00443 
LRPRl 
EST00443 
LRPRl 
EST00443 
LRPRl 
EST00443 
LRPRl 
EST00443 
II. 
4 
LRPRl 
CCATTCAGTAGCTTCTCTGAGATAAAGCCACTTCTTCTTGCTCTCTTC 
** ** l ************** * ** ********* l *** ******** * ** 
CCTTTTAGTAGCTTCTCTTG~CCACTTCTTTTTGTC 
1 60 
1693 
TTTACATCATCCATTTATTTCAAGTGCAGTCTTCTTCAAn 
********* ****t*********** t** * ***** ********** l * ***** 
TTTACATCAACCATTTATTTCAAGTGTGTAGTGTGCTTCAGAGTCTG~GAGCTATTGCAG 
120 
1753 
AATTGGtn;TTGTGGCTCTCThCAGAAGCACAGGTGCAGCCCATGACAGA~AGTCCTCTG 
****t********t*tt **** ** ** ** l ** * *** *t******** 
AATTGGCTGTTGTGGCTTTCTATGGACATTCACATTCACATG~CCTGTTAC~CAGTCCTCTA 
180 
1813 
GAGACAACTTTGGGTGGATCCATGGATTCTGTGTCTGTGTCTCAGTTGATTGAGTACATA~CT~ 
*fft*~**********tt****** l ***et**** * l t*i * *z ***i *** 
GAGACAACTTTGGGTGGATCCATGAACTCTCTG~TCT~CTGATCCACTATGTA~T~ 
240 
la73 
CTGTCCATGGTGGCAATACGCCTGGAGAGCAGCAGTACATACTAG~~CTTTATTTTG 
** l *** **tt* *** ********* ** *** ** * ************** 
CTATCCACTACTGCAATGCGCTTGGAGAGCAACAATACTTTCTTGCT~ACTTTATTTTG 
300 
1933 
GACTTCTATGAGAAGGTGTGTGACATATATATAAATTATGACCTTCCAT~GGT~TGTTG 
** ********************************* ** ********** **** * 
GATTTCTATGAGAAGGTGn=TGACATATATATAAATNATAT 
360 
1976 
TTT.CCTCCTGTG.GTCTTTCATT.CTGCATTCCTAAGCTTGGATG 
*t ******* * ** *** * ***** **** *** *** 
GTTTCCTCCTGGGGATCCTTCTATTCTGCACTCCTCAGCCTGGG 
. 404 
57 516 
PFSSFSEIKPLLLDHLAPLFFTSSIYFKCSLLQCLKDLLLLWLSTQVQPMTDSPL 
*******r**** l *** *** **t**t ** **:****t***** : t *.*** 
EST00443 PFSSFSEVKPLLFDHWISXFTSTSYFKCSVLQSLKELLQNWLLWLSMDIHMKPVTNSPL 
1 60 
576 
LRPRl ETTLGGSMDSVSQLIEYIGWLSMVAIRLESSSTLLVHFILDLPLWL 
********.*** ** *:**** * **** * * **************** :**** 
EST00443 ETTLGGSM&VSKLIHYVGWLSTTAMHLESNNTFLLHFILDFYEKVCDIYINXNLPLVGI 
120 
592 
LRPRl FPP.WFHSAFLSLDAT 
* ** *** 
EST00443 VSSWGSFYSALLSL 
. 134 
Fig. 3. Comparison of DNA sequence (I) and amino acid sequence (II) of LRPRl with those of the expressed sequence tag ESTOO4t3, isolated from a 
human brain cDNA library (Adams et al., 1992). Asterisks indicate identity between the two sequences. In the protein sequence comparison, non- 
identical positions are indicated by a colon. 
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500) 
50 ) 
5 ng/ml 
0.5 ) 
0 ) 
(Bu),cAM 
forskolin 
FSH 
P 
Fig. 4. Effect of FSH, forskolin and (Bu)zcAMP on LRPRl mRNA 
expression in rat Sertoli cells. Sertoli cells were isolated from 21-day- 
old rats, cultured for 3 days without FSH (see Section 2), and then 
incubated in the presence of o-FSH-S16 (0, 0.5, 5, 50 or 500 ng/ml), 
forskolin (20pM). or (Bu)zcAMP (0.5 n&l), for 4 h. Total RNA 
(20pg/lane) was isolated and subjected to Northern blot analysis using 
an LRPRl cDNA probe. 
(Bu)~cAMP or 20pM forskolin (Fig. 4). FSH induces 
LRPRI mRNA expression in a dose-dependent manner, 
with an EDsn between 5 and 50 @ml ovine-FSH-S16. 
Similar FSH dose-response relationships have been re- 
ported for other parameters of Sertoli cells using this FSH 
preparation (Themmen et al., 1991). 
To study the specificity of the effect of FSH on LRPRl 
mRNA expression, Sertoli cells were, after a 3-day period 
of pre-incubation, treated for 4 h with several other agents 
(0.1 @ml and 100 ng/ml IGF-I, 0.5 ng/ml and 5 pg/ml 
insulin, 10-s M R1881, 1O-8 M PMA, or 10e8 M PA), and 
Fig. 5. LRPRl mRNA expression in rat Sertoli cells is specifically Fig. 7. Tissue specificity of LRPRl mRNA expression. Total RNA 
regulated by FSH. Sertoli cells were isolated from 21-day-old rats, (20&ane) from different issues was isolated and subjected to North- 
cultured for 3 days without FSH, and then incubated in the presence of em blot analysis using an LRPRl cDNA probe. Abbreviations: Te21, 
insulin (0.5 ng/ml or 5pg/ml), IGF-I (0.1 ng/ml or 100 @ml), R1881 
(10e8 M), PMA (10m8 M), PA (10e8 M), (Bu)zcAMP (0.5 mM) or FSH 
testis of 21-day-old rat; Te, testis of adult rat; 0~30, ovary of 30 day- 
old-rat; Li, liver; Sp, spleen; In, intestine; Lu, lung; He, heart; Mu, 
(500 rig/ml), for 4 h. Total RNA (20pg/lane) was isolated and sub- muscle; Br, brain; Pi, pituitary gland; Pr, prostate; Ep, epididymis; Se, 
jected to Northern blot analysis using an LRPRl cDNA probe. seminal vesicle (non-gonadal tissues were from adult rats). 
Fig. 6. Effects of cycloheximide and actinomycin D on LRPRI mRNA 
expression. Sertoli cells were isolated from 21-day-old rats, cultured for 
3 days without FSH, and then pm-incubated with or without actinomy- 
tin D (AD, 5 yg/ml) or cycloheximide (CX, SO@ml), for 30 min. 
Subsequently, the cells were incubated in the presence or absence of o- 
FSH-S16 (500 &ml) or (Bu)zcAMP (0.5 mM), for 4 h. Total RNA 
(5pgiIane) was isolated and subjected to RNase protection analysis 
using an LRPRl anti-sense RNA probe. An anti-sense GAPDH probe 
was used to assure the intactness of the loaded RNA. 
with 0.5 mM (Bu)~cAMP and 500 ng/ml FSH. None of 
the tested hormones and growth factors, besides FSH (and 
(Bu),cAMP), were found to exert an effect on LRPRf 
mRNA expression (Fig. 5). Thus, the available data indi- 
cate that LRPRI mRNA expression, under the present 
conditions, is specifically regulated by FSH. 
FSH induction of LRPRI mRNA expression was in- 
hibited by treating Sertoli cells with the transcription in- 
hibitor actinomycin D (5,~glml), but was not inhibited 
when FSH was added in the presence of the protein syn- 
thesis inhibitor cycloheximide (50,@ml) (Fig. 6). This 
indicates that LRPRI mRNA expression is transcription- 
ally regulated by FSH, through a direct mechanism which 
is independent of de novo protein synthesis. In the RNase 
protection assay not only the specific 322 bp protected 
fragment was found, but also some less abundant non- 
specific bands which are due to incomplete breakdown of 
the probe. 
LRPRl mRNA was not found in isolated cell prepara- 
tions of pachytene spermatocytes, round spermatids or 
peritubular myoied cells (results not shown). However, 
LRPRI mRNA expression is not limited to the testis. 
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Fig. 8. Effect of FSH on LRPRI mRNA expression in vivo and in vitro. Left: 21-day-old rats were injected i.p. with o-FSH-S16 (1 pg/ gram body 
weight) and sacrificed at different ime points (0, 2,4,6, 8 h) after injection. Total testis RNA (20,@ane) was isolated and subjected to Northern blot 
analysis u ing an LRPRI cDNA probe. Right: Sertoli cells isolated from 21-day-old rats were incubated in the presence of o-FSH-S16 (500 @ml), 
following 3 days of culture without FSH. Total RNA was isolated at different ime points after addition of FSH (0, 0.5, 1, 2, 4, 8, 16, 24.48, 72 h), and 
subjected to Northern blot analysis as described for the left panel. 
RelativeIy low expression levels were found in spleen, 
ovary, lung, and in brain tissue (Fig. 7). 
To investigate FSH effects on LRPRl mRNA expres- 
sion in vivo, intact 21-day-old rats were treated with FSH 
(single i.p. injection), and testicular LRPRZ mRNA ex- 
pression was measured at several time points after this 
injection, using Northern analysis of total testicular RNA 
(Fig. 7). There is a considerable basal level of testicular 
LRPRI mRNA expression in intact rats, whereas the basal 
level of LRPRI mRNA expression in Sertoli cells after 
3 days of culture in the absence of FSH was very low 
(Fig. 8). It was observed that testicular LRPRI mRNA 
expression in these immature rats was very rapidly in- 
creased by administration of exogenous FSH. A notable 
increase in testicular LRPRI mRNA expression can first 
be seen at 2 h after injection, with a maximal effect at 4 h 
(Fig. 8). This is similar to the time course of LRPRI 
mRNA induction that was observed using isolated Sertoli 
cells (Fig. 8). 
3 6 9 27wk 
c, 
Fig. 9. Testicular mRNA expression of LRPRl at different ages. Total 
testis RNA (20pgIlane) was isolated from rats at 3, 6, 9 and 27 weeks 
of age, and subjected to Northern blot analysis using an LRPRI cDNA 
probe. 
The LRPRl mRNA expression level declined after 8- 
16 h of FSH stimulation, both in vitro and in vivo, and a 
very low level was found after 24 h. In the cultured cells, 
LRPRI mRNA expression reappeared 48 h after addition 
of FSH. These later time-points were not tested in the in 
vivo experiment, where only a single FSH injection was 
given, which probably will not result in a long-term in- 
creased level of circulating FSH. 
Maturation of Sertoli cells, and different interactions 
with the developing germ cells, may have pronounced 
effects on expression of various genes in Sertoli cells 
(Pineau et al., 1990). Therefore we measured LRPRl 
mRNA expression in testes from rats of 3, 6, 9 and 
27 weeks old, i.e. during and after the initiation of sper- 
matogenesis (Fig. 9). A marked decrease in LRPRI 
mRNA expression was observed during testis develop- 
ment. The fact that pachytene spermatocytes and spermat- 
ids do not express LRPRI mRNA, may explain that the 
relative level of testicular expression of LRPRZ mRNA 
declines with the appearance of increasing numbers of the 
more advanced germ cell types. However, it cannot be 
excluded that adult Sertoli cells have a lower level of 
LRPRf mRNA expression compared to immature Sertoli 
cells. 
4. Discussion 
We cloned and characterized LRPRI, a cDNA clone 
which encodes a leucine-rich protein with a molecular 
mass of 85.6 kDa. Database analysis did not reveal sig- 
nificant homology to proteins with known functions, but 
gave some information on specific motifs that are present 
in the LRPRl protein sequence, such as a leucine zipper 
and possible phosphorylation sites. However, neither a 
nuclear localization signal nor a signal sequence is pres- 
ent in the LRPRl protein sequence, indicating that 
LRPRl will not be transported over the nuclear envelope 
or excreted by the cell. Thus, LRPRl might be located in 
the cytoplasm. 
LRPRl mRNA expression is highest in testis, although 
the mRNA can also be found in ovary, lung, spleen and 
brain. Little can yet be learned about the function of 
LRPRl protein from the expression of LRPRl mRNA in 
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these different tissues, but more information on LRPRl 
function may be obtained when LRPRl antibodies have 
been developed that can be used for (sub)cellular local- 
ization studies. 
In Sertoli cells, the LRPRI mRNA expression level 
was found to be rapidly and dose-dependently up- 
regulated by FSH through the CAMP pathway. Further- 
more, the present results indicate that this up-regulation 
involves a direct mechanism at the transcriptional level, 
which does not require FSH-induced de novo synthesis of 
other gene regulatory proteins. 
LRPRI mRNA expression in cultured Sertoli cells 
from immature rats is, under the present conditions, up- 
regulated by FSH but not influenced by the other hor- 
mones and growth factors which we have tested. This 
indicates that LRPRJ mRNA expression might be specifi- 
cally regulated by FSH. However, effects of other agents 
on LRPRI mRNA expression in cultured Sertoli cells, 
under various conditions, remain to be investigated. 
The temporal pattern of FSH regulation of LRPRI 
mRNA expression is quite similar in both the in vitro and 
in vivo situations. However, the basal LRPRI mRNA 
level is higher in vivo than it is in cultured Sertoli cells, 
probably because the cultured cells have not been ex- 
posed to FSH for 3 days, whereas a basal evel of LRPRI 
mRNA expression in vivo will be maintained by circulat- 
ing FSH. After the rapid induction of LRPRI mRNA ex- 
pression by addition of FSH to cultured Sertoli cells, ex- 
pression declined to control levels during 16 h of incuba- 
tion in the continuous presence of FSH, followed by long- 
term up-regulation (48 h), which indicates that the Sertoli 
cells reach a new steady state. In the intact animal, after 
the increase of testicular LRPRZ mRNA expression as a 
response to a single FSH injection, down-regulation of 
this mRNA expression below the basal level was also 
observed. 
Transient up-regulation of LRPRI mRNA expression 
followed by down-regulation may be the result of a loss 
of sensitivity of the Sertoli cells to FSH. Loss of respon- 
siveness can be caused by ligand-induced down- 
regulation of FSH receptor mRNA and protein (Themmen 
et al., 1991) in combination with other mechanisms 
causing desensitization (Zhang et al., 1991; Benovic et 
al., 1987). 
The observation that the in vivo temporal pattern of 
regulation of LRPRl mRNA expression is similar to the 
in vitro pattern, indicates the usefulness of studying the 
molecular mechanism of the regulation of LRPRl mRNA 
expression by FSH. 
According to criteria described by Roesler et al. 
(1988), concerning genes of which transcription is in- 
duced by CAMP, two general categories can be postu- 
lated. Group 1 genes are rapidly regulated by CAMP, 
whereas transcription of genes in Group 2 is increased 
only after several hours of increased CAMP levels. Also, 
in most cases, CAMP induction of the genes in Group 1 
is cycloheximide insensitive. The action of FSH on 
LRPRl mRNA expression indicates that the LRPRl gene 
falls into Group 1 of this classification. This is also 
true for the c-fos and a-inhibin genes. The c-fos, a- 
inhibin and LRPRI mRNA levels in Sertoli cells are rap- 
idly up-regulated by FSH, and in all cases no inhibition of 
mRNA expression was seen when translation was inhib- 
ited by cycloheximide (Hall et al., 1988; Klaij et al., 
1990). 
In the promoters of both the c-fos and a-inhibin genes, 
CAMP responsive lements (CREs) have been identified 
(Muller, 1986; Pei et al., 1991). Since the LRPRI gene 
can be compared to the c-fos and a-inhibin genes with 
respect o the response to FSI-IfcAMP, it is very possible 
that one or more CREs are also present in the LRPRl 
gene promoter. We are currently characterizing the pro- 
moter of the LRPRI gene, to study the DNA sequences 
that are involved in regulation of LRPRZ mRNA expres- 
sion by FSH, and also to use the promoter in combination 
with a reporter gene in in vitro studies of FSH action. 
Moreover, LRPRl could prove to be a very useful pa- 
rameter for evaluation of FSH action both in vivo and in 
vitro. Compared to c-fos, LRPRl shows a response which 
is very specific for FSH. We have tested several agents 
(insulin, IGF-I, R1881, PMA and PA), but regulators of 
LRPRI mRNA expression other than FSH have not yet 
been found. Furthermore, the Sertoli cell-specific LRPRl 
mRNA expression responds more rapidly to FSH com- 
pared to other known FSH-regulated genes such as a- 
inhibin, tissue type plasminogen activator and transferrin, 
which are found in many other cell types. Because of its 
sensitive, rapid and cell specific response, and the fact 
that FSH acts on LRPRl expression both in vitro and in 
vivo, LRPRl might be a very useful marker of FSH ac- 
tion. 
In conclusion, we cloned and sequenced a cDNA, 
LRPRl , representing the so-called leucine-rich primary 
response gene-l, which encodes a leucine-rich protein 
with unknown function. LRPRI mRNA shows a rela- 
tively high expression in Sertoli cells, and its expression 
in these cells is very rapidly induced by FSH both in situ 
and in cell culture, through a primary response mecha- 
nism. 
Acknowledgements 
This work was supported by the Dutch Ministry of 
WVC (The Alternatives to Animal Experiments Platform) 
and the Dutch Research Council through GB-MW. Ovine 
FSH-S16 was provided by the NIH (Bethesda, MD, 
USA), and IGF-I was a kind gift of Dr. J. Foekens, Dr 
Daniel den Hoed Cancer Center, Rotterdam, The Nether- 
lands. The authors wish to thank A. Verkerk (Department 
of Cell Biology, Erasmus University Rotterdam, Rotter- 
dam, The Netherlands) for the development and mainte- 
nance of the RNA-DNA-protein analysis oftware. 
124 K.E. Slegtenhorst-Eegdema et al. I Molecular and Cellular Endocrinology 108 (1995) 115-124 
References 240, 1759-1764. 
Adams, M.D., Dubnick, M., Kerlavage, A.R., Moreno, R., Kelley, J.M., 
Utterback, T.R., Nagle, J.W., Fields, C. and Venter, J.C. (1992) 
Nature 355.632-634. 
Auffray, C. and Rougeon, F. (1980) Eur. J. Biochem. 107,303-314. 
Baarends, W.M., van Helmond, M.J.L., Post, M., van der Schoot, 
P.J.C.M., Hoogerbrugge, J.W., de Winter, J.P., Uilenbroek, J.T.J., 
Karels, B., Wilming, L.G., Meijers, J.H.C., Themmen, A.P.N. and 
Grootegoed, J.A. (1994) Development 120, 189-197. 
Bardin, C.W., Cheng, C.Y., Mustow, N.A. and Gun&us, G.L. (1994) 
in The Physiology of Reproduction, Second Edition (Knobil, E. and 
Neil], J.D., eds.), pp. 1291-1333, Raven Press, New York. 
Benovic, J.L., Kllhn, H., Weyand, I., Codina, J., Caron, M.G. and 
Letkowitz, R.J. (1987) Proc. Natl. Acad. Sci. USA 84,8879-8882. 
Busch, S.J. and Sassone-Comi, P. (1990) Trends Genet. 6,3aO. 
Clermont, Y. and Harvey, SC. (1967) in Ciba Foundation Colloquia on 
Endocrinology, Vol 16 (Churchill, J. ed.), pp. 173-189. 
Devereux, J. (1992) The GCG sequence analysis software package, 
Version 7.1 Genetics Computer Group Inc. Univ. Res. Park, Madi- 
son, WI, USA. 
Laemli, U.K. (1970) Nature 227,680-685. 
Marshall, G.R., Jockenhbvel, F., Lildecke, D. and Nieschlag, E. (1986) 
Acta Endocrinol. 113.424431. 
Means, A.R., Fakunding, J.L., Huckins, C., Tindall, D.J. and Vitale, R. 
(1976) Rec. Prog. Horm. Res. 32,477-522. 
Moudgal, N.R., Ravindranath, N., Murthy, G.S., Dighe, R.R., Aravin- 
dan, G.R. and Martin, F. (1992) J. Reprod. Fertil. 96.91-102. 
Muller, R. (1986) Biochim. Biophys. Acta 823.207-225. 
Nargolwalla, C., McCabe, D. and Fritz, LB. (1990) Mol. Cell. Endocri- 
nol. 70,73-80. 
Norton, J.N. and Skinner, M.K. (1992) Mol. Endocrinol. 6,2018-2026. 
O’Shea, E.K., Rutkowski, R. and Kim, P.S. (1989) Science 243, 538- 
542. 
Pei, L., Dodson, R., Schoderbek, W.E., Maurer, R.A. and Mayo, K.E. 
(1991) Mol. Endocrinol. 5521-534. 
Pineau, C., Sharpe, R.M., Saunders, P.T., Gerard, N. and Jegou, B. 
(1990) Mol. Cell. Endocrinol. 72, 13-22. 
Reventos, J., Hammond, G.L., Crozat, A., Brooks, D.E., Gun&us, 
G.L., Bardin, C.W. and Musto, N.A. (1988) Mol. Endocrinol. 2, 
125-132. 
Dorrington, J.H., Roller, N.F. and Fritz, LB. (1975) Mol. Cell. Endocri- 
nol. 3.57-70. 
Roesler, W.J., Vandenbark, G.R. and Hanson, R.W. (1988) J. Biol. 
Chem. 263.9063-9066. 
Fort, Ph., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, Ch., Jean- 
teur, Ph. and Blanchard, J.M. (1985) Nucleic Acids. Res. 13, 1431- 
1442. 
Hagenas, L., Ritzen, E.M., Ploen, L., Hansson, V., French, F.S. and 
Nayfeh, S.N. (1975) Mol. Cell. Endocrinol. 2.339-350. 
Hall, S.H., Joseph, D.R., French, F.S. and Conti, M. (1988) Mol. Endo- 
crinol. 2,55-6 1. 
Rossi, P., Dolci, S., Albanesi, C., Grimaldi, P., Ricca, R. and Geremia, 
R. (1993) Dev. Biol. 155,68-74. 
Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: 
A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, NY. 
Sanger, F., Nicklen, S. and Coulson, A.R. (1977) Proc. Natl. Acad. Sci. 
USA 74.5463. 
Hansson, V., Weddington, SC., McLean, W.S., Smith, A.A., Nayfeh, 
S.N., French, F.S. and Ritzen, E.M. (1975a) J. Reprod. Fertil. 44, 
363-375. 
Hansson, V., Weddington, SC., Petrusz, P., Ritzen, E.M., Nayfeh, S.N. 
and French, F.S. (1975b) Endocrinology 97.469-473. 
Huggenvik, J.I., Idzerda, R.L., Haywood, L., Lee, D.C., McKnight, 
G.S. and Griswold, M.D. (1987) Endocrinology 120.332-340. 
Klaij, I.A., Toebosch, A.M.W., Themmen, A.P.N., Shimasaki, S., de 
Jong. F.J. and Grootegoed, J.A. (1990) Mol. Cell. Endocrinol. 68, 
45-52. 
Smith, E.P., Hall, S.H., Monaco, L., French, F.S., Wilson, E.M. and 
Conti, M. (1989) Ann. N. Y. Acad. Sci. 564, 132-139. 
Steinberger, E. (1971) Physiol. Rev. 51, l-22. 
Themmen, A.P.N., Blok, L.J., Post, M., Baarends, W.M., Hoogerbrugge, 
J.W., Parmentier, M., Vassart, G. and Grootegoed, J.A. (1991) Mol. 
Cell. Endocrinol. 78, R7-R13. 
Thiesen, H.J. (1990) New Biol. 2,363-374. 
Toebosch, A.M.W., Robertson, D.M., Trapman, J., Klaassen, P., de Paus, 
R.A., de Jong, F.H. and Gmotegoed, J.A. (1988) Mol. Cell. Endocri- 
nol. 55, 101-105. 
Kozak, M. (1987) Nucleic Acids Res. 20, 8125-8132. 
Kozak, M. (1989) J. Cell. Biol. 108,229-241. 
Landschulz, W.H., Johnson, P.F. and McKnight, S.L. (1988) Science 
Toebosch, A.M.W., Robertson, D.M., Klaij, I.A., de Jong, F.H. and 
Grootegoed, J.A. (1989) J. Endocrinol. 122.757-762. 
Zhang, S., Dattatreyamurty. B. and Reichert, L.E. (1991) Endocrinology 
128,295-302. 
